Migraine prevention in the real world: Exploring the role of anti-CGRP antibodies - Modules 1 & 2

touchCLINICAL PERSPECTIVES for touchNEUROLOGY - Module 1 & 2  Module 1 Listen first to an expert provide their insights on the burden of migraine for patients, the need for effective preventive therapy and the currently available preventive treatment options. The expert Professor Simona Sacco - University of L’Aquila, Italy Module 2 Listen next to a patient advocate providing her insights on the burden of migraine for patients and then to a clinical expert as he shares his perspectives on how real-world data for anti-CGRP antibodies can inform treatment optimization. The patient advocate  Ms Elena Ruiz de la Torre - European Migraine & Headache Alliance, Spain The clinical expert Professor Mamoru Shibata - Ichikawa General Hospital, Chiba, Japan This touchPODCAST is for HCPs only. This activity is funded by an educational grant from Eli Lilly and Company Limited. This medical education is provided by touchIME. For further information visit our website:   https://touchneurology.com/the-role-of-anti-CGRP-antibodies-in-migraine-prevention/